Applying the AFRAID and FRIGHT Clocks to Novel Preclinical Mouse Models of Polypharmacy. Issue 7 (21st March 2022)

• Record Type: Journal Article
• Authors: Mach, John; Kane, Alice E; Howlett, Susan E; Sinclair, David A; Hilmer, Sarah N
• Editors: Anderson,, Rozalyn M
• Is Part Of: Journals of gerontology. Volume 77:Issue 7(2022)
• Page Start: 1304
• Page End: 1312
• Publication Date: 2022-03-21
• Subjects: Biological age -- Deprescribing -- Lifespan -- Mortality -- Polypharmacy; Geriatrics -- Periodicals; Gerontology -- Periodicals; 618.97
• DOI: 10.1093/gerona/glac067
• Languages: English
• ISSNs: 1079-5006

Abstract

Abstract: The Frailty Inferred Geriatric Health Timeline (FRIGHT) and Analysis of Frailty and Death (AFRAID) clocks were developed to predict biological age and lifespan, respectively, in mice. Their utility within the context of polypharmacy (≥5 medications), which is very common in older adults, is unknown. In male C57BL/6J(B6) mice administered chronic polypharmacy, monotherapy, and undergoing treatment cessation (deprescribing), we aimed to compare these clocks between treatment groups; investigate whether treatment affected correlation of these clocks with mortality; and explore factors that may explain variation in predictive performance. Treatment (control, polypharmacy, or monotherapy) commenced from age 12 months. At age 21 months, each treatment group was subdivided to continue treatment or have it deprescribed. Frailty index was assessed and informed calculation of the clocks. AFRAID, FRIGHT, frailty index, and mortality age did not differ between continued treatment groups and control. Compared to continued treatment, deprescribing some treatments had inconsistent negative impacts on some clocks and mortality. FRIGHT and frailty index, but not AFRAID, were associated with mortality. The bias and precision of AFRAID as a predictor of mortality varied between treatment groups. Effects of deprescribing some drugs on elements of the clocks, particularly on weight loss, contributed to bias. Overall, in this cohort, FRIGHT and AFRAID measures identified no treatment effects and limited deprescribing effects (unsurprising as very few effects on frailty or mortality), with variable prediction of mortality. These clocks have utility, but context is important. Future work should refine them for intervention studies to reduce bias from specific intervention effects.